# HYALURONIDASE

NDC: 51662-1555
Generic name: HYALURONIDASE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20210604

FDA application: BLA021859

## Active ingredients

- HYALURONIDASE (HUMAN RECOMBINANT): 150 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1555"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1555
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3f1db01-58bf-2226-e053-2a95a90a8b33